Jul 18, 2012 10:36am EDT OPKO Health Announces License for Topically Active Formulation of Ranibizumab
Jul 17, 2012 9:20am EDT OPKO Scientist Reports Results at Alzheimer’s Association International Conference
Jul 16, 2012 8:30am EDT OPKO Health Announces Appointment of Juan F. Rodriguez as Chief Financial Officer
May 04, 2012 9:14am EDT OPKO Health Enters into License Agreement with International Health Technology for Next Generation Prostate Cancer Biomarker Panel